Literature DB >> 6940735

Therapeutic quandary: asymptomatic primary biliary cirrhosis associated with polymyositis.

R A Willson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6940735     DOI： 10.1007/bf01308383

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  32 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

2.  Multisystem involvement in chronic liver disease. Studies on the incidence and pathogenesis.

Authors:  P L Golding; M Smith; R Williams
Journal:  Am J Med       Date:  1973-12       Impact factor: 4.965

3.  Cell-mediated cytotoxicity to muscle in polymyositis. Effect of immunosuppression.

Authors:  R L Dawkins; F L Mastaglia
Journal:  N Engl J Med       Date:  1973-03-01       Impact factor: 91.245

4.  Immune complexes in acute and chronic liver disease.

Authors:  H C Thomas; D De Villiers; B Potter; H Hodgson; S Jain; D P Jewell; S Sherlock
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

5.  Polymyalgia rheumatica and primary biliary cirrhosis.

Authors:  J C Robertson; G F Batstone; W Y Loebl
Journal:  Br Med J       Date:  1978-10-21

6.  Asymptomatic primary biliary cirrhosis. Presentation, histology, and results with D-penicillamine.

Authors:  C R Fleming; J Ludwig; E R Dickson
Journal:  Mayo Clin Proc       Date:  1978-09       Impact factor: 7.616

7.  In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis.

Authors:  J M Vierling; D L Nelson; W Strober; D M Bundy; E A Jones
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

8.  Adverse effects of D-penicillamine in rheumatoid arthritis.

Authors:  H B Stein; A C Patterson; R C Offer; C J Atkins; A Teufel; H S Robinson
Journal:  Ann Intern Med       Date:  1980-01       Impact factor: 25.391

9.  Receptor specific clearance by the reticuloendothelial system in chronic liver diseases. Demonstration of defective C3b-specific clearance in primary biliary cirrhosis.

Authors:  C J Jaffe; J M Vierling; E A Jones; T J Lawley; M M Frank
Journal:  J Clin Invest       Date:  1978-11       Impact factor: 14.808

10.  A controlled trial of D-penicillamine therapy in primary biliary cirrhosis.

Authors:  S Jain; P J Scheuer; S Samourian; J O McGee
Journal:  Lancet       Date:  1977-04-16       Impact factor: 79.321
View more
  3 in total

1.  Polymyositis associated with primary biliary cirrhosis.

Authors:  K A Boki; S P Dourakis
Journal:  Clin Rheumatol       Date:  1995-05       Impact factor: 2.980

2.  Inflammatory myopathy associated with anti-mitochondrial antibodies: A distinct phenotype with cardiac involvement.

Authors:  Jemima Albayda; Aamna Khan; Livia Casciola-Rosen; Andrea M Corse; Julie J Paik; Lisa Christopher-Stine
Journal:  Semin Arthritis Rheum       Date:  2017-06-13       Impact factor: 5.532

3.  A case of polymyositis in a patient with primary biliary cirrhosis treated with D-penicillamine.

Authors:  J H Ahn; T H Kim; K R Peck; Y W Song
Journal:  Korean J Intern Med       Date:  1993-01       Impact factor: 2.884
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.